Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 24 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thompson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, for the WHI Investigators. Menopausal Hormone therapy and long-term all-cause and cause-specific mortality. The Women’s Health Initiative randomized trials. JAMA 2017;318:927-38. [Ref.ID 102070]
2.Tiene citas relacionadas Cita con resumen
Lee DSH, Markwardt S, Goeres L, Lee CG, Eckstrom E, Williams C, Fu R, Orwoll E, Cawthon PM, Stefanick ML, Mackey D, Bauer DC, Nielson CM. Statins and physical activity in older men. The Osteoporotic Fractures in Men Study. JAMA Intern Med 2014;174:1263-70. [Ref.ID 97621]
3.Tiene citas relacionadas Cita con resumen
Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBland ES, Vaughan L, Robinson J, Rapp SR, Goveas JS, Lane D, Wactawski-Wende J, Stefanick ML, Li W, Resnick SM, WHIMSY Study Group. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 2013;173:1429-36. [Ref.ID 95976]
4. Cita con resumen
Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initative observational study. J Natl Cancer Inst 2013;105:526-35. [Ref.ID 95454]
5.Tiene citas relacionadas Cita con resumen
Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML. HRT and cardiovascular events. Safety couldn't be investigated. BMJ 2012;345:26. [Ref.ID 94208]
6.Tiene citas relacionadas
Chlebowski RT, Stefanick ML, Anderson GL. Breast cancer in postmenopausal women after hormone therapy. In reply. JAMA 2011;305:466-7. [Ref.ID 90149]
7.Tiene citas relacionadas Cita con resumen
Chlebowski BT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, for the WHI Investigators. Estrogen plus progesting and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684-92. [Ref.ID 89533]
8.Tiene citas relacionadas
Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA, for the Women's Health Initiative Investigators. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51. [Ref.ID 86903]
9.Tiene citas relacionadas Cita con resumen
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G, for the WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2008;360:573-87. [Ref.ID 85166]
10.Tiene citas relacionadas Cita con resumen
Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SAA, Brzyski R, Chlebowski RT, Gass M, Lacroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, for the WHI Investigators. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestagen. JAMA 2008;299:1036-45. [Ref.ID 82293]
11.
Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007;298:2389-98. [Ref.ID 81795]
12.Tiene citas relacionadas Cita con resumen
Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77. [Ref.ID 79789]
13.Tiene citas relacionadas
Stefanick ML. Risk-benefit profiles of raloxifene for women. N Engl J Med 2006;355:190192. [Ref.ID 77743]
14.Tiene citas relacionadas
Howard BV, Anderson GL, Caan B, Hsia J, Johnson K, Limacher M, Manson JE, Prentice RL, Stefanick ML, Wassertheil-Smoller S, Van Horn L, for the Writing Groups for the WHI Investigators. Low-fat diet and cardiovascular disease. JAMA 2006;296:280-1. [Ref.ID 77610]
15.Tiene citas relacionadas Cita con resumen
Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT, for the WHI Investigators. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006;295:1647-57. [Ref.ID 76773]
16.Tiene citas relacionadas
Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, Tinker L, Vitolins M, Prentice R. Low-fat dietary pattern and weight change over 7 years. The women's health initiative dietary modification trial. JAMA 2006;295:39-49. [Ref.ID 76499]
17.Tiene citas relacionadas
Howard BV, Horn LV, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al.. Low-fat dietary pattern and risk of cardiovascular disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:655-66. [Ref.ID 76433]
18.Tiene citas relacionadas
Shumaker SA, Legault C, Kuller L, Rapp S R, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, for the Women's Health Initiative Memory Study Investigators. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study. JAMA 2004;291:2947-58. [Ref.ID 70431]
19.Tiene citas relacionadas Cita con resumen
Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 2004;291:47-53. [Ref.ID 68645]
20.Tiene citas relacionadas Cita con resumen
Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative randomized trial. JAMA 2003;290:1729-38. [Ref.ID 67705]
Seleccionar todas
 
 1 a 20 de 24 siguiente >>